Table 2 Descriptive clinicopathological characteristics of patients included in the study
From: Polymorphisms in autophagy genes are genetic susceptibility factors in glioblastoma development
Tumor | Glioblastoma (N = 174) | |
|---|---|---|
N | % | |
Sex | ||
Male | 89 | 53.6 |
Female | 77 | 46.4 |
Mean age, years [IQR] | 62.22 [27–79] | |
Tumor location | ||
Hemisphere | ||
Right | 83 | 50.3 |
Left | 66 | 40 |
Other | 16 | 9.7 |
Lobe | ||
Frontal | 45 | 27.1 |
Temporal | 47 | 28.3 |
Parietal | 30 | 18.1 |
Occipital | 8 | 4.8 |
Other | 36 | 21.7 |
Surgery | ||
Total resection | 97 | 71.9 |
Subtotal resection | 38 | 28.1 |
Post-surgery treatment | ||
None | 10 | 6.1 |
Radiotherapy | 58 | 35.4 |
Radiotherapy + Chemotherapy | 96 | 58.5 |
Median survival, days [IC 95%] | 413.15 [7–4119] | |